Last reviewed · How we verify

NCT06481046

Treatment of Rotator Cuff Tears With Platelet Rich Plasma

Withdrawn NA Last updated 1 July 2024
What this trial tests

NA trial testing Platelet Rich Plasma (PRP) in Rotator Cuff Tears. Withdrawn.

Timeline
23 January 2015
Primary endpoint
25 January 2015
25 January 2015

Quick facts

Lead sponsorThe Foundation for Orthopaedics and Regenerative Medicine
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date23 January 2015
Primary completion25 January 2015
Estimated completion25 January 2015
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The Foundation for Orthopaedics and Regenerative Medicine

Who can join

Adults 18 to 90, any sex, with Rotator Cuff Tears or Rotator Cuff Tendinitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the safety and effectiveness of dual platelet rich plasma (PRP) injections into the rotator cuff insertion and the area of the tendon proximal to the insertion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Platelet Rich Plasma (PRP)

Trials testing the same drug.

Other recruiting trials for Rotator Cuff Tears

Currently open trials in the same condition.

Other The Foundation for Orthopaedics and Regenerative Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06481046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing